Evaluation of Alexithymia in Chronic Pain Patients With Spinal Cord Stimulation
Recruiting now
Conditions studied: Chronic Pain
In brief
The purpose of this study is to investigate the relationship between alexithymia levels and clinical parameters, including pain intensity and quality of life, in chronic pain patients treated with spinal cord stimulation (SCS). Chronic neuropathic pain can lead to psychological distress and decreased quality of life. While SCS is an effective neuromodulation therapy for managing refractory pain, patient outcomes vary significantly, suggesting that biomedically similar patients experience different levels of relief due to psychosocial factors. Alexithymia, characterized by difficulties in identifying and describing emotions, may significantly influence the individual pain experience and treatment outcomes. In this cross-sectional observational study, patients who underwent SCS implantation for clinical indications will be evaluated. Clinical data regarding pain history will be collected retrospectively from patient files, while psychosocial profiles will be assessed at a single time point using validated psychometric questionnaires. The study aims to contribute to a better understanding of psychosocial variables in neuromodulation outcomes, potentially aiding in improved patient selection and expectation management.
Key facts
- Study ID
- NCT07696286
- Run by
- Marmara University
- People needed
- 20
- Starts
- 2026-06-01
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-07-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- - Being 18 years of age or older
- Having undergone permanent spinal cord stimulation (SCS) implantation due to clinical indications
- Providing written informed consent for study participation
- Being literate
- Having the cognitive capacity to complete the psychometric scales
- No active, severe psychiatric disorders requiring immediate treatment (e.g., schizophrenia, bipolar affective disorder, severe psychotic disorders)
You may not qualify if…
- Cognitive impairment or communication barriers that compromise the capacity to provide informed consent
- Presence of active psychotic disorders or manic episodes
- Suspected self-harm or suicide risk during the clinical interview
- Presence of specific secondary causes that could explain the pain (e.g., active malignancy, active infection, acute fracture)
Where it is running
- Marmara University Pendik Training and Research Hospital — Istanbul, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.